Built on Strong Partnerships and Strategic Alliances

Partnerships are critical to our vision of developing therapeutics in areas of high unmet need.

Spero Therapeutics believes that collaborating with partners is essential to develop innovative therapies and serve the needs of patients. We have a strong record of collaborating with the government, academic institutions, and pharmaceutical companies from preclinical to clinical development.

Since its founding, Spero has built strategic partnerships to advance its multi-asset, clinical-stage pipeline. As a growing clinical stage biopharmaceutical company, we have alliances with or received funding support from the following:

We intend to continue collaborating with government agencies, non-profit foundations, and pharmaceutical partners to support the development of our product candidates.

Spero Therapeutics welcomes inquiries regarding potential partnering opportunities for our current pipeline candidates and/or in-licensing new candidates in therapeutic indications adjacent to our current pipeline including, but not limited to, rare and pulmonary diseases.

For more information about partnership opportunities, contact us.